Lyra Therapeutics Inc. (LYRA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Perceptive Advisors

Joseph Edelman

12,757,562 $2,628,057 0.07%
2.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

1,965,689 $405,718 -30% 0.05%
3.
Ikarian Capital

Neil Shahrestani

1,058,148 $218,403 +1% 0.02%
4.
ADAR1 Capital Management

Daniel Schneeberger

533,200 $110,052 0.02%
5.
Two Sigma Advisors

John Overdeck And David Siegel

385,500 $79,567 -17% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.96 25,000 261,966 2023-11-10 Filing
$2.43 1,203,612 Large Shareholder 2,521,745 2023-05-31 Filing
$2.43 197,946 Large Shareholder 1,107,370 2023-05-31 Filing
$2.43 403,858 Large Shareholder 2,259,301 2023-05-31 Filing
$2.43 1,203,612 Large Shareholder, Director 2,521,745 2023-05-31 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$16.00 16,909 Large Shareholder 457,421 2020-05-05 Filing
$16.00 7,255 Large Shareholder 478,123 2020-05-05 Filing
$16.00 5,568 Large Shareholder 324,057 2020-05-05 Filing
$16.00 11,360 Large Shareholder 661,153 2020-05-05 Filing
$16.00 7,255 Large Shareholder, Director 478,123 2020-05-05 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 3,109,798 $641,862 0%
2. 1,787,422 $368,209 0%
3. 885,966 $182,891 0%
4. 555,508 $114,657 0%
5. 488,720 $100,872 0%
News See All